Preview: Acurx Pharmaceuticals's Earnings
Portfolio Pulse from Benzinga Insights
Acurx Pharmaceuticals (NASDAQ:ACXP) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.29. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $1.81, down 58.43% over the last 52-week period.
August 11, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acurx Pharmaceuticals is expected to report an EPS of $-0.29. Despite beating EPS estimates in the past, the company's share price has typically dropped. The stock is down 58.43% over the last year.
Acurx Pharmaceuticals has a history of beating EPS estimates but this has not translated into a rise in share price. Given the negative returns over the past year, investors are likely bearish going into this earnings release.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100